Journal of Clinical Medicine (May 2024)

Prospective Analysis of Squamous Cell Carcinoma Antigen-1 and -2 for Diagnosing Sinonasal Inverted Papilloma

  • Hitoshi Hirakawa,
  • Taro Ikegami,
  • Masatomo Toyama,
  • Yurika Ooshiro,
  • Tomoyo Higa,
  • Hidetoshi Kinjyo,
  • Shunsuke Kondo,
  • Norimoto Kise,
  • Yukashi Yamashita,
  • Mikio Suzuki

DOI
https://doi.org/10.3390/jcm13092721
Journal volume & issue
Vol. 13, no. 9
p. 2721

Abstract

Read online

Background: The goal of this research was to confirm whether preoperative serum squamous cell carcinoma antigen (SCCA)-1 and -2 levels are useful diagnostic markers for sinonasal inverted papilloma (IP) in a prospective study. Methods: Participants were 102 patients who underwent consecutive endoscopic sinus surgery: 18 with IP, two with other types of papilloma, 77 with chronic rhinosinusitis, four with sinonasal cancer, and one with hemangioma. SCCA-1 and SCCA-2 were measured preoperatively by an automatic chemiluminescence immunoassay and an enzyme-linked immunosorbent assay, respectively. Results: SCCA-1 and SCCA-2 values were significantly correlated (r = 0.603, p p = 0.035). We recommend a cutoff value of 1.8 ng/mL for SCCA-1 in IP diagnosis. Conclusions: SCCA-1 and SCCA-2 when combined with imaging and pathology hold promise for enhancing the preoperative detection of IP, which would be a valuable contribution to clinical practice.

Keywords